Physicians Go Digital Across the Globe - Webinar May 19

Manhattan ResearchPhysician consumption of digital information sources for professional purposes is accelerating across the U.S., Europe and Asia, according to pharmaceutical and healthcare market research company Manhattan Research. Doctors across the globe are increasing their reliance on the Internet to access journals, medical references, news, conferences, and continuing medical education, diminishing the relevance of the offline versions of these resources each year. Additionally, physicians in these markets visit online resources at multiple points a day through both computers and mobile devices to support clinical decisions, make recommendations to patients, and stay up-to-date with the latest advances in the medical field.

This outlook of the global physician market comes from Manhattan Research's recently released suite of Taking the Pulse® studies. The suite is comprised of three studies that provide insight on the latest technology adoption and usage trends among physicians in the U.S., Europe and Asia, respectively.

"Judging by the rapid increase in physician technology adoption we've seen over the past five years, we expect to see the Internet overtake its traditional counterparts as the go-to source of professional information for physicians in the near future," said Mark Bard, President of Manhattan Research. "For pharma, biotech and device companies targeting physicians in the U.S., Europe and Asia, it’s important for their brands to leverage digital channels in promotional efforts to reach the large majority of physicians using the Internet to aid product and treatment decisions throughout the day."

On May 19, 2009 at 11am ET, President Mark Bard will host a webinar highlighting some of the key global physician channel shifts and will give a holistic view of how digital is evolving physician marketing and CRM strategies across the world.

Questions to be answered in the webinar include:

  • How does physician technology adoption and integration differ in the U.S., Europe and Asia - and can certain similarities across regions help companies to market more efficiently?
  • Discover areas of unmet demand for pharmaceutical promotion - For which online channels do physician demand exceed supply, revealing opportunities for innovative companies to satisfy these unmet needs?
  • It's been said that the sales rep is dead - but is this really true across all industry markets? How is the role of the sales rep evolving in the U.S., Europe and Asia, and how can companies leverage emerging technologies for more efficient sales strategies on a global level?
The Digital Doctor Goes Global: Using Emerging Technologies to Improve Physician Marketing & CRM in the U.S., Europe and Asia

Tuesday, May 19, 2009 11:00 AM - 11:40 AM ET

Sign up here: https://www2.gotomeeting.com/register/821006419

About Taking the Pulse® U.S., Europe and Asia
Taking the Pulse® U.S., Europe and Asia are three separate market research and strategic advisory service focused on which technologies physicians have adopted, how they are currently using them, and how they plan to use them in the future. This year's Taking the Pulse® was conducted in Q1 2009 among a nationally representative sample of 1,900 practicing U.S. physicians, while the Europe and Asia versions were conducted in Q4 2008 and both include a sample of 1,000 practicing physicians. Topics include the Internet, Web 2.0 technologies, email communication, PDAs/smartphones, search engines, detailing/tech-enabled sales reps, patient interaction/education, and digital health infrastructure.

In addition to the data, clients receive strategic deliverables including research reports, client briefings, and access to the Manhattan Research analyst team to answer specific questions.

For additional product and subscription information, please visit http://www.manhattanresearch.com/products/Physician.aspx.

About Manhattan Research
Manhattan Research, a Decision Resources, Inc. company, is a leading market research and advisory services firm for global pharmaceutical and healthcare companies. For more information, visit http://www.manhattanresearch.com.

About Decision Resources, Inc.
Decision Resources, Inc. is a cohesive portfolio of companies that offers best-in-class, high-value information and insights on important sectors of the healthcare industry. Clients rely on this analysis and data to make informed decisions. Please visit Decision Resources, Inc. at http://www.decisionresourcesinc.com.

Most Popular Now

NextPoint Therapeutics announces $80 million Serie…

NextPoint Therapeutics, a biotechnology company developing a new world of precision immuno-oncology, announced today that it raised $80 million in Series B financing co-l...

AstraZeneca to acquire CinCor Pharma to strengthen…

AstraZeneca has entered into a definitive agreement to acquire CinCor Pharma, Inc. (CinCor), a US-based clinical-stage biopharmaceutical company, focused on developing no...

Bayer to accelerate drug discovery with Google Clo…

Bayer AG and Google Cloud announced a collaboration to drive early drug discovery that will apply Google Cloud's Tensor Processing Units (TPUs), which are custom-develope...

Incurable liver disease may prove curable

Research led by Associate Professor Duc Dong, Ph.D., has shown for the first time that the effects of Alagille syndrome, an incurable genetic disorder that affects the li...

Scientists develop a cancer vaccine to simultaneou…

Scientists are harnessing a new way to turn cancer cells into potent, anti-cancer agents. In the latest work from the lab of Khalid Shah, MS, PhD, at Brigham and Women’s ...

Acquisition of Neogene Therapeutics completed

AstraZeneca has completed the acquisition of Neogene Therapeutics Inc. (Neogene), a global clinical-stage biotechnology company pioneering the discovery, development and ...

Study identifies potential new approach for treati…

Targeting iron metabolism in immune system cells may offer a new approach for treating systemic lupus erythematosus (SLE) - the most common form of the chronic autoimmune...

Nanotechnology may improve gene therapy for blindn…

Using nanotechnology that enabled mRNA-based COVID-19 vaccines, a new approach to gene therapy may improve how physicians treat inherited forms of blindness. A collabo...

Modified CRISPR-based enzymes improve the prospect…

Many genetic diseases are caused by diverse mutations spread across an entire gene, and designing genome editing approaches for each patient’s mutation would be impractic...

Pfizer expands 'An Accord for a Healthier World' p…

Pfizer Inc. (NYSE: PFE) announced that it has significantly expanded its commitment to An Accord for a Healthier World to offer the full portfolio of medicines and vaccin...

500,000 missed out on blood pressure lowering drug…

Nearly half a million people missed out on starting medication to lower their blood pressure during the COVID-19 pandemic, according to research supported by the British ...

Roche announces the European Commission approval o…

Roche (SIX: RO, ROG; OTCQX: RHHBY) announced that the European Commission (EC) has approved Xofluza® (baloxavir marboxil) in children aged one year and above for the trea...